Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1

Conditions

Ovarian Neoplasms 2Prostatic Neoplasms 1Peripheral Nervous System Diseases 1Endometrial Neoplasms 1

Interventions

Paclitaxel 2sagopilone 1allantoicase 1Vitamin B Complex 1Sodium Selenite 1Sodium Chloride 1Saline Solution 1Prednisolone 1Physical Therapy Modalities 1Omacor 1Low-Level Light Therapy 1Fish Oils 1Fatty Acids, Omega-3 1Drug Therapy 1Carboplatin 1Bevacizumab 1BID protein, human 1Amifostine 1Acetylcarnitine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Peripheral Nervous System Diseases × BID protein, human × Gynecologic × Clear all
NCT00751205 2014-10-28

Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)

Bayer

Phase 2 Completed
150 enrolled
GenitourinaryGynecologic

Ovarian Neoplasms, Peripheral Nervous System Diseases, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡